Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) — Stella

Home/Immunization/

View on ClinicalTrials.gov

Recruiting

Back to Immunization trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Texas Medical Branch, Galveston, Texas

Key details

Phase

Post-approval study

Sponsor

The University of Texas Medical Branch, Galveston

Collaborators

Cancer Prevention Research Institute of Texas

Enrollment target

~618 participants

Started

January 2023

Primary completion

August 2026

Age range

27 Years – 45 Years

Sex

Female only

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.